With the analysis among 24,795 patents, we discovered top 474 key players by total patent application. F. Hoffmann-La Roche Ltd., Smithkline Beckman Corp, Novartis AG are dominant in this area. They take 13.75% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Pennsylvania, United States
Patent: 853
Basel-Stadt, Switzerland
Patent: 764
New Jersey, United States
Patent: 739
Indiana, United States
Patent: 688
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 660
Antwerpen, Belgium
Patent: 590
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 570
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 458
New Jersey, United States
Patent: 417
With the analysis among 294 patents, we discovered top 39 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, KaNDy Therapeutics Ltd., Pipeline Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Herefordshire, United Kingdom
Patent: 24
Pipeline Therapeutics, Inc.
California, United States
Patent: 19
Illinois, United States
Patent: 18
Ionova Life Science Co. Ltd.
Guangdong Sheng, China
Patent: 15
California, United States
Patent: 12
Minnesota, United States
Patent: 9
New Hampshire, United States
Patent: 8
North Carolina, United States
Patent: 7
Karnataka, India
Patent: 4
With the analysis among related 2,271 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Idorsia Pharmaceuticals Ltd., Suven Life Sciences Ltd., Neurocrine Biosciences, Inc. take 7.27% of patent filing during this period.
Idorsia Pharmaceuticals Ltd.
Andhra Pradesh, India
Patent: 57
Neurocrine Biosciences, Inc.
California, United States
Patent: 46
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 42
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 41
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 40
Vanda Pharmaceuticals, Inc.
District of Columbia, United States
Patent: 35
California, United States
Patent: 32
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 32
Basel-Stadt, Switzerland
Patent: 30
With the analysis among related 2,271 patents in last 5 years, we discover 262 new entrants. Beijing Tide Pharmaceutical Co., Ltd., Vanda Pharmaceuticals, Inc., Magenta Therapeutics, Inc. are the most active new entrants in this area.
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 42
Vanda Pharmaceuticals, Inc.
District of Columbia, United States
Patent: 35
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 26
undefined undefined
Patent: 22
Pipeline Therapeutics, Inc.
California, United States
Patent: 19
Massachusetts, United States
Patent: 16
Shandong Danhong Pharmaceutical Co., Ltd.
Shandong Sheng, China
Patent: 13
New Jersey, United States
Patent: 12
With the analysis among 1,968 patents, we discovered top 261 universities and scientific research institutions by total patent application. Dartmouth College, Kyushu University, Emory University are dominant in this area. They take 14.74% of the total patent filing.
New Hampshire, United States
Patent: 42
Fukuoka-ken, Japan
Patent: 40
Georgia, United States
Patent: 35
Connecticut, United States
Patent: 33
Tennessee, United States
Patent: 29
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 27
Ontario, Canada
Patent: 24
Minnesota, United States
Patent: 21
Washington, United States
Patent: 20
Baylor College of Medicine
Texas, United States
Patent: 20